Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Do

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 20, 2026
Symptomatic Changes Associated With a Pharmacist-Led COPD ProgramEdward C Portillo, Steven Do, Scott Hetzel, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2008
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientationQing Lu, Zheng Chen, John Perumattam, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2015
Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitorsHuiyong Hu, Xiaojing Wang, Grace Ka Yan Chan, et al.
Cancer Research|November 13, 2003
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivoJames G Christensen, Randall Schreck, Jon Burrows, et al.
Journal of Medicinal Chemistry|April 27, 2017
Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized BioavailabilityXiaojing Wang, Aleksandr Kolesnikov, Suzanne Tay, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Cis-amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Nicole Blaquiere, Vickie Tsui, et al.
Journal of Medicinal Chemistry|October 12, 2011
Rational design of phosphoinositide 3-kinase α inhibitors that exhibit selectivity over the phosphoinositide 3-kinase β isoformTimothy P Heffron, Binqing Wei, Alan Olivero, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Structure-based design of thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Michael Siu, Richard Goldsmith, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2023
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug designJames J Crawford, Jianwen Feng, Hans D Brightbill, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 20, 2026
Symptomatic Changes Associated With a Pharmacist-Led COPD ProgramEdward C Portillo, Steven Do, Scott Hetzel, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2008
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientationQing Lu, Zheng Chen, John Perumattam, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2015
Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitorsHuiyong Hu, Xiaojing Wang, Grace Ka Yan Chan, et al.
Cancer Research|November 13, 2003
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivoJames G Christensen, Randall Schreck, Jon Burrows, et al.
Journal of Medicinal Chemistry|April 27, 2017
Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized BioavailabilityXiaojing Wang, Aleksandr Kolesnikov, Suzanne Tay, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Cis-amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Nicole Blaquiere, Vickie Tsui, et al.
Journal of Medicinal Chemistry|October 12, 2011
Rational design of phosphoinositide 3-kinase α inhibitors that exhibit selectivity over the phosphoinositide 3-kinase β isoformTimothy P Heffron, Binqing Wei, Alan Olivero, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Structure-based design of thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Michael Siu, Richard Goldsmith, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2023
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug designJames J Crawford, Jianwen Feng, Hans D Brightbill, et al.
Pageof 3